Trial Profile
A Study to Evaluate the Antitumour Activity of Cabazitaxel in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients Pretreated With Abiraterone or Docetaxel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 May 2016 New trial record